SCHEMBL12480408

SCHEMBL12480408

CC(C)(C)OC(=O)N1CC(O)(CO[Si](C)(C)C(C)(C)C)CC1C(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 10/20 0.42
KLK7 P49862 1/20 0.41
MITF O75030 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
PARP1 P09874 1/20 0.37
CTSL P07711 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ABCB1 P08183 1/20 0.36
ELANE P08246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12479707 1.00 FKBP1A (0.42) FKBP1AKLK7MITFMAPTHTT
SCHEMBL12480970 1.00 FKBP1A (0.42) FKBP1AKLK7MITFMAPTHTT
SCHEMBL18578230 0.91 FKBP1A (0.41) FKBP1AMITFMAPTHTT
SCHEMBL21789823 0.88 FKBP1A (0.41) FKBP1AKLK7MITFMAPTHTT
SCHEMBL12480646 0.88 FKBP1A (0.41) FKBP1AKLK7MITFMAPTHTT
SCHEMBL13967436 0.86 FKBP1A (0.43) FKBP1AKLK7PARP1CTSLABCB1
SCHEMBL12480719 0.86 FKBP1A (0.43) FKBP1AKLK7PARP1CTSLABCB1
SCHEMBL18591179 0.86 FKBP1A (0.43) FKBP1AKLK7PARP1CTSLMEN1
SCHEMBL18591180 0.86 FKBP1A (0.43) FKBP1AKLK7PARP1CTSLMEN1
SCHEMBL16635290 0.83 IMPDH2 (0.40) FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661433-A1 INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) Novartis AG (CH) 2013-11-13 EP disclosed
WO-2012093101-A1 INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) NOVARTIS AG (CH) 2012-07-12 WO disclosed